ALTERATIONS IN THE SIGNAL-TRANSDUCING MOLECULES OF T-CELLS AND NK CELLS IN COLORECTAL TUMOR-INFILTRATING, GUT MUCOSAL AND PERIPHERAL LYMPHOCYTES - CORRELATION WITH THE STAGE OF THE DISEASE

被引:195
作者
MATSUDA, M
PETERSSON, M
LENKEI, R
TAUPIN, JL
MAGNUSSON, I
MELLSTEDT, H
ANDERSON, P
KIESSLING, R
机构
[1] KAROLINSKA INST,CTR MICROBIOL & TUMOR BIOL,S-17177 STOCKHOLM,SWEDEN
[2] YAMANASHI MED COLL,DEPT SURG,YAMANASHI 40938,JAPAN
[3] CALEB MED LABS,STOCKHOLM,SWEDEN
[4] DANA FARBER CANC INST,BOSTON,MA
[5] SODER SJUKHUSET,DEPT SURG,STOCKHOLM,SWEDEN
[6] KAROLINSKA SJUKHUSET,RADIUMHEMMET,STOCKHOLM,SWEDEN
关键词
D O I
10.1002/ijc.2910610605
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
T cells from mice bearing an experimental colon carcinoma, and from patients with colorectal and renal carcinomas, have atypical T-cell receptors (TCR). In the present study, further characterization of modulations in CD3- and CD16-associated zeta chain in peripheral blood lymphocytes (PBL) and tumorinfiltrating lymphocytes (TIL) from colorectal carcinomas was performed. Relative to PBL, the percentage of natural killer (NK) cells among fresh TIL was reduced, while a higher proportion of T cells expressing HLA-DR was found. As previously reported, we found significantly reduced levels of the CD3- and CD16-associated zeta chain in TIL and, to a lesser extent, also in patients' PBL. Levels of zeta chain in T and NK cells from non-cancerous colorectal tissue from patients were lower than in PBL but higher than in TIL, with a direct relationship between levels of this signal-transducing molecule and the distance from the tumor. In addition, zeta levels correlated with the Dukes' stage of the disease, since PBL from patients with lymph-node involvement or distant organ metastases (Dukes' stages C and D) had significantly less CD3 zeta than patients with localized disease (stages A and B). Patients' T cells also had decreased levels of cell-surface and cytoplasmic CD3 epsilon. We also observed reduced levels of the TCR accessory molecules CD4 and CD8, mainly on TIL but to a lesser extent also on patients' PBL. Biochemical analysis of anti-CD3 epsilon-immunoprecipitated TCR complexes demonstrated that the CD3 complex was not associated with the zeta chain, either on TIL or on PBL or on lymphocytes from non-cancerous colon tissue, suggesting a defect in the assembly of the TCR complex. Following several days of in vitro culture with recombinant interleukin-2 and phytohemagglutinin, anti-CD3 or anti-CD2 monoclonal antibodies (MAbs), levels of CD3 zeta chain as well as of cell surface CD3 epsilon were normalized. Our findings suggest an abnormal expression as well as assembly of several different signal-transducing molecules of T cells and NK cells, which correlate with the stage of the disease in patients with colorectal carcinomas. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:765 / 772
页数:8
相关论文
共 29 条
  • [1] Anderson P., Blue M.-L., O'Brien C., Schlossman S.F., Monoclonal antibodies reactive with the T cell receptor ζ chain: production and characterization using a new method, J. Immunol., 143, pp. 1899-1904, (1989)
  • [2] Anderson P., Caligiuri M., O'Brien C., Manley T., Ritz J., Schlossman S.F., Fcγ receptor type III (CD16) is included in ζ NK receptor complex expressed by human natural killar cells, Proc. nat. Acad. Sci. (Wash.), 87, pp. 2274-2278, (1990)
  • [3] Atallah M.M., Motawea A.A., El-Chennawy F.A., Attallah A.F., Immunological assays following exposure to halothane in clinical usage, Europ. J. Anaesthesiol., 8, pp. 459-464, (1991)
  • [4] Baniyash M., Garcia-Morales P., Bounifacino T.S., Samelson L.E., Klausner R.D., Disulfide linkage of the ζ and η chains of T cell receptor, J. biol. Chem., 263, pp. 9874-9878, (1988)
  • [5] Bierer B.E., Sleckman B.P., Ratnofsky S.E., Burakoff S.J., The biologic roles of CD2, CD4 and CD8 in T‐cell activation, Ann. Rev. Immunol., 7, pp. 579-599, (1989)
  • [6] Birgess K.E., Odysseos A.D., Zalvan C., Druker B., Andersson P., Schlossman S.F., Rudd C.E., Biochemical identification of a direct physical interaction between the CD4:p56luk and Ti(TCR)/CD3 complexes, European Journal of Immunology, 21, pp. 1663-1668, (1991)
  • [7] Chin Y., Janseens J., Vandepitte J., Vandenbrande J., Opdebeek L., Raus J., Phenotypic analysis of tumor‐infiltrating lymphocytes from human breast cancer, Anticancer Res., 12, pp. 1463-1466, (1992)
  • [8] Diaz J.I., Edinger M.G., Stoler M.H., Tubbs R.R., Activated T‐cell subsets in benign lymphoid hyperplasias and B‐cell non‐Hodgkin's lymphomas, Amer. J. Pathol., 139, pp. 503-509, (1991)
  • [9] Finke J.H., Zea A.H., Stanley J., Longo D.L., Mizoguchi H., Tubbs R.R., Wiltrout R.H., O'Shea J.J., Kudoh S., Klein E., Bukowski R.M., Ochoa A., Loss of T‐cell receptor ζ chain and p56<sup>lck</sup> in T‐cell infiltrating human renal‐cell carcinoma, Cancer Res., 53, pp. 5613-5616, (1993)
  • [10] Glaichenhaus N., Shastri N., Littman D.R., Turner J.M., Requirement for association of p56lck with CD4 in antigen‐specific signal transduction in T cells, Cell, 64, pp. 511-520, (1991)